Lates News

Neurogene (NGNE.US): The Q1 2025 financial report achieved revenue of 0 US dollars, compared to 0 US dollars in the previous period. Earnings per share were -1.08 US dollars, compared to -1.00 US dollars in the previous period, with an expected value of -0.92 US dollars.